PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsdiabetes mellitus
MeSH D003920 - diabetes mellitus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D044882:Glucose metabolism disorders
1 Company
2 Drugs
$
Success rate
D004700:Endocrine system diseases
0 Companies
0 Drugs
Success rate
D003920: 
Diabetes mellitus
11 Companies
14 Drugs
$
Success rate
D000071698:Latent autoimmune diabetes in adults
0 Companies
0 Drugs
Success rate
D003921:Experimental diabetes mellitus
0 Companies
0 Drugs
Success rate
D003922:Type 1 diabetes mellitus
10 Companies
9 Drugs
$
Success rate
D003924:Type 2 diabetes mellitus
102 Companies
40 Drugs
$
Success rate
D011236:Prediabetic state
0 Companies
0 Drugs
Success rate
D016640:Gestational diabetes
0 Companies
0 Drugs
Success rate
D056731:Donohue syndrome
0 Companies
0 Drugs
Success rate
D048909:Diabetes complications
6 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AstraZenecaDapagliflozin, Saxagliptin Qtern  2016-07-15 $5 M Y2017 
SanofiInsulin glulisine Apidra  2004-09-27   
Insulin human Insulin Human Winthrop  2007-01-17   
Insulin aspart Insulin aspart Sanofi  2020-06-25   
Insulin lispro Insulin lispro Sanofi  2017-07-19   
Insulin human Insuman  1997-02-21   
Insulin glargine Lantus  2000-06-09   
Insulin glargine Toujeo (previously Optisulin)  2000-06-26   
Insulin aspart Truvelog Mix  2022-04-25   
Merck Sharp & DohmeInsulin glargine Lusduna  2017-01-03   
PfizerInsulin human Exubera  2006-01-24   
Eli LillyInsulin glargine Abasaglar (previously Abasria)  2014-09-09   
Glucagon Baqsimi  2019-12-16 $699 M Q2/22-Q3/23 
Insulin lispro Humalog  1996-04-30 $1,741.2 M Q2/23-Q1/24 
Insulin lispro Liprolog  1997-05-07   
Insulin lispro Lyumjev (previously Liumjev)  2020-03-24   
ViatrisInsulin glargine Semglee  2018-03-23   
BaxterInsulin Inpremzia  2022-04-25   
Novo NordiskInsulin Actraphane  2002-10-07   
Insulin human Actrapid  2002-10-07   
Insulin aspart Fiasp  2017-01-09   
Insulin Insulatard  2002-10-07   
Insulin detemir Levemir  2004-06-01   
Insulin Mixtard  2002-10-07   
Insulin Monotard  2002-10-07   
Insulin aspart NovoMix  2000-08-01   
Insulin aspart NovoRapid  1999-09-07   
Semaglutide Ozempic  2018-02-08   
Insulin Protaphane  2002-10-07   
Insulin aspart, Insulin degludec Ryzodeg  2013-01-21   
Insulin degludec Tresiba  2013-01-20   
Insulin Ultratard  2002-10-07   
Insulin Velosulin  2002-10-07   
ZentivaDuloxetine Duloxetine Zentiva  2015-08-20   
AMMTeKGlibenclamide Amglidia  2018-05-24   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
71%
44/62
Phase 2
55%
55/100
Phase 3
59%
72/123
Approved: 15Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AstraZeneca
Dapagliflozin,
Saxagliptin,
Exentide
Sanofi
Insulin aspart,
Insulin glargine,
Insulin glulisine,
Insulin human,
Insulin lispro
Merck Sharp & Dohme
Insulin glargine,
Benzocaine,
Antithrombin iii,
Omarigliptin,
Sodium chloride,
Sodium lactate,
Microcrystalline cellulose,
Retinol,
Mk0767
Pfizer
Insulin human,
Rucaparib,
Rucaparib camsylate,
Vitamin e,
Aglatimagene besadenovec,
Retinol
Eli Lilly
Glucagon,
Insulin lispro,
Insulin glargine,
Ruboxistaurin,
Avexitide,
Sodium chloride
Baxter
Insulin,
Insulin human,
Insulin, isophane
Novo Nordisk
Semaglutide,
Insulin lispro,
Insulin aspart,
Insulin degludec,
Insulin glulisine,
Insulin detemir,
Insulin glargine,
Insulin human,
Insulin, isophane,
Insulin icodec,
Insulin,
INSULIN 287,
Sodium chloride,
Sodium lactate,
Microcrystalline cellulose,
Ideglira
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use